【晶泰科技(02228.HK)与辉瑞深化战略合作,共建AI药物与新材料研发分子模拟平台】智通财经APP获悉,今天,全球领

智通财经
30 Jun
【晶泰科技(02228.HK)与辉瑞深化战略合作,共建AI药物与新材料研发分子模拟平台】智通财经APP获悉,今天,全球领先的 AI+机器人药物与新材料研发创新平台晶泰科技(02228.HK)宣布与全球生物制药巨头辉瑞公司扩大战略合作,共同开发全新一代的分子模拟平台以驱动新药研发。此次合作旨在进一步融合先进的物理算法的精确度与前沿 AI 模型的速度和规模化能力,从而全面提升分子模拟平台的效率、精度和所覆盖的化学空间广度,显著加速小分子药物的发现与开发进程。基于晶泰科技与辉瑞已有的战略合作研发成果,两家公司将对现有平台进行强化升级,打造兼具高精度与更高通量优势的预测工具,以应对辉瑞快速拓展的小分子化学空间与持续升级的研发需求。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10